COMMUNIQUÉS West-GlobeNewswire

-
Terveystalo's occupational health services to expand: Terveystalo acquires the occupational health operations from Welfare District of Forssa
17/06/2019 -
NeuroSearch announces a change to its financial outlook for 2019
17/06/2019 -
VBI Vaccines to Host Conference Call Tomorrow to Review PROTECT Phase 3 Clinical Data for Sci-B-Vac®
16/06/2019 -
Strategy update for the three-year period 2020-2022
16/06/2019 -
Apellis Pharmaceuticals
16/06/2019 -
ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile
15/06/2019 -
Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual Meeting
15/06/2019 -
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
15/06/2019 -
Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress
15/06/2019 -
Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma
15/06/2019 -
Emerald Health Therapeutics applaudit le gouvernement du Canada pour la publication de la version définitive des réglementations encadrant les produits ingérables
15/06/2019 -
Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference
14/06/2019 -
UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
14/06/2019 -
Emerald Health Therapeutics Applauds the Government of Canada for the Release of Final Ingestible Regulations
14/06/2019 -
UPDATE - Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019 -
Canada House Wellness Group Inc. Update on Canada House Clinic Expansion
14/06/2019 -
Cytovance® Biologics Inc., Completes Its Second FDA Pre-Approval Inspection (PAI) of Oklahoma City, OK Facilities
14/06/2019 -
LifePod and iHome Announce Strategic Collaboration to Launch Groundbreaking Proactive-Voice Virtual Caregiver Service
14/06/2019 -
Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
Pages